Serum DNase I, soluble Fas/FasL levels and cell surface Fas expression in patients with SLE: a possible explanation for the lack of efficacy of hrDNase I treatment

By Tinazzi Elisa   Puccetti Antonio   Gerli Roberto   Rigo Antonella   Migliorini Paola   Simeoni Sara   Beri Ruggero   Dolcino Marzia   Martinelli Nicola   Corrocher Roberto   Lunardi Claudio  

International Immunology, Vol. 21, Iss. 3, 2009-03 ,pp. : 237-243

Oxford University Press

Access to resources Recommend Favorite

Do Elevated Levels of Serum-Soluble Fas Contribute to the Persistence of Activated Lymphocytes in Systemic Lupus Erythematosus?

By Bijl M.   van Lopik T.   Limburg P.C.   Spronk P.E.   Jaegers S.M.H.J.   Aarden L.A.   Smeenk R.J.T.   Kallenberg G.G.M.  

Journal of Autoimmunity, Vol. 11, Iss. 5, 1998-10 ,pp. : 457-463

Academic Press

Access to resources Recommend Favorite

Serum-soluble Fas antigen level in patients with allergic rhinitis: Its relation to specific immunotherapy

By Kinikli Gülay   Ateş Aşkın   Turgay Murat   Aydoğan Nergis     Tokgöz Güner  

Allergy and Asthma Proceedings, Vol. 27, Iss. 2, 2006-03 ,pp. : 145-147

OceanSide Publications, Inc

Access to resources Recommend Favorite

Elevated Soluble CD27 Levels in Serum of Patients with Systemic Lupus Erythematosus

By Font J.   Pallares L.   Martorell J.   Martinez E.   Gaya A.   Vives J.   Ingelmo M.  

Clinical Immunology, Vol. 81, Iss. 3, 1996-12 ,pp. : 239-243

Academic Press

Access to resources Recommend Favorite

Clinical Significance of Serum Soluble Fas, Fas Ligand and Fas in Intrahepatic Lymphocytes in Chronic Hepatitis C

By Zaki Maysaa El Sayed   Auf Fatma Abbas   Ghawalby Nabieh Anwar El   Saddal Nirmeen Mohamed El  

Immunological Investigations, Vol. 37, Iss. 2, 2008-02 ,pp. : 163-170

Informa Healthcare

Access to resources Recommend Favorite